Syntheses of isotope-labeled SGLT2 inhibitor canagliflozin (JNJ-28431754)

Lin, RH; Hoerr, DC; Weaner, LE; Salter, R

Lin, RH (reprint author), Janssen Pharmaceut Co Johnson & Johnson, Janssen Res & Dev LLC, Welsh & McKean Rd, Spring House, PA 19477 USA.

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017; 60 (13): 616

Abstract

Canagliflozin (Invokana, JNJ-28431754) is an orally bioavailable and selective SGLT2 (subtype 2 sodium-glucose transport protein) inhibitor approved f......

Full Text Link